Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 21/08/2026 5-day change 1st Jan Change
17.92 CNY -3.71% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -6.91% -4.53%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 8.14B 1.21B 1.04B 970M 888M 1.67B 116B 1.69B 11.46B 4.47B 58.18B 4.54B 4.45B 192B P/E 2026 *
18.7x
P/E 2027 * 16.4x
Enterprise Value 8.66B 1.29B 1.1B 1.03B 945M 1.77B 123B 1.8B 12.19B 4.76B 61.89B 4.84B 4.73B 205B EV / Sales 2026 *
2.31x
EV / Sales 2027 * 2.01x
Free-Float
51.96%
Yield 2026 *
1.67%
Yield 2027 * 2.7%
06-10 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-27 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
30/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
14/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
30/04/25 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
1 day-3.71%
1 week-6.91%
Current month+5.29%
1 month+10.55%
3 months+6.79%
6 months-5.39%
Current year-4.53%
1 week 17.72
Extreme 17.72
19.59
1 month 15.43
Extreme 15.43
20.26
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
23.5
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 30/03/2023
Director of Finance/CFO 51 28/04/2022
Corporate Officer/Principal 45 27/10/2020
Director TitleAgeSince
Chairman 63 12/05/2008
Director/Board Member 53 25/12/2019
Director/Board Member 51 10/01/2020
Date Insider Type Main position Quantity % Market Cap.
24/05/23 Buy 3,000 0.0009%
23/05/23 Buy 1,000 0.0003%
04/09/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-3.71%-6.91%-23.42%+2.40% 1.21B
+3.61%+5.34%-50.05%-57.01% 32.12B
+1.74%+1.27%+37.05%+105.05% 11.98B
-1.39%+2.78%-19.53%+5.33% 3.89B
+0.61%-0.15%-2.64%+25.52% 3.25B
-2.69%-6.50%+39.78%+34.15% 2.05B
-0.85%-1.41%+8.23%+16.40% 1.95B
+3.24%+5.70%+15.12%+142.78% 1.47B
-2.04%+1.98%-13.20%-41.45% 1.02B
-0.70%-0.56%-6.00%-23.29% 957M
Average -0.22%+0.05%-1.47%+20.99% 5.99B
Weighted average by Cap. +2.07%+2.92%-19.64%-3.65%

Financials

2026 *2027 *
Net sales 3.75B 558M 478M 447M 409M 768M 53.38B 778M 5.28B 2.06B 26.82B 2.09B 2.05B 88.7B 4.22B 628M 538M 503M 460M 864M 60.05B 876M 5.94B 2.32B 30.16B 2.36B 2.31B 99.77B
Net income 427M 63.47M 54.37M 50.87M 46.57M 87.4M 6.07B 88.55M 601M 234M 3.05B 238M 233M 10.09B 508M 75.54M 64.71M 60.55M 55.42M 104M 7.23B 105M 715M 279M 3.63B 284M 277M 12.01B
Net Debt 519M 77.26M 66.18M 61.92M 56.68M 106M 7.39B 108M 732M 285M 3.71B 290M 284M 12.28B 337M 50.13M 42.94M 40.18M 36.78M 69.02M 4.8B 69.93M 475M 185M 2.41B 188M 184M 7.97B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
21/08/26 CN¥17.92 -3.71% 8,362,207
20/08/26 CN¥18.61 +1.09% 9,151,378
19/08/26 CN¥18.41 -2.28% 8,546,214
18/08/26 CN¥18.84 -0.37% 6,299,325
17/08/26 CN¥18.91 -1.77% 6,564,900
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
17.92CNY
Average target price
20.41CNY
Spread / Average Target
+13.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock